The largest database of trusted experimental protocols

B6.129 1 gt rosa 26sortm1 eyfp cos j

Manufactured by Jackson ImmunoResearch

B6.129×1-Gt(Rosa)26Sortm1(EYFP)Cos/J is a transgenic mouse strain that expresses the enhanced yellow fluorescent protein (EYFP) under the control of the Rosa26 promoter. This mouse line can be used for lineage tracing and other applications that require fluorescent protein expression.

Automatically generated - may contain errors

4 protocols using b6.129 1 gt rosa 26sortm1 eyfp cos j

1

Genetic Labeling of Astrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
GLAST-CreERT2 transgenic mice12 (link) were crossed to the Rosa26-enhanced yellow fluorescent protein (EYFP)47 (link) or Rosa26-tdTomato48 (link) Cre-reporter lines (obtained from the Jackson Laboratory, B6.129×1-Gt(Rosa)26Sortm1(EYFP)Cos/J, JAX stock: 006148; B6.Cg-Gt(Rosa)26Sortm14(CAG-tdTomato)Hze/J, JAX stock: 007914) to generate GLAST-CreERT2;R26R-EYFP or GLAST-CreERT2;R26R-tdTomato mice in which CreERT2 is hemizygous and Rosa26-EYFP or Rosa26-tdTomato is either heterozygous or homozygous. For a set of experiments, GLAST-CreERT2;R26R-EYFP were further crossed to Rasless mice27 (link) to generate GLAST-CreERT2;Rasless;R26R-EYFP mice, hereafter referred to as GLAST-Rasless-EYFP mice. All Rasless mice used were homozygous for H-Ras and N-Ras null alleles and homozygous for floxed K-Ras alleles.
All animals were in a C57BL/6J genetic background and ≥8 weeks old at the onset of experiments. Animals were housed in group in a pathogen-free facility with controlled humidity (50 ± 15%) and temperature (22 ± 2 °C), with 12:12-h light:dark cycles and free access to food and water. All experimental procedures were performed in accordance to the Swedish and European Union guidelines and approved by the institutional ethical committees (Stockholms Norra Djurförsöksetiska Nämnd or Malmö/Lunds Djurförsöksetiska Nämnd).
+ Open protocol
+ Expand
2

Fate Mapping of T Helper Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 (B6), B6.SJL-Ptprca Pepcb/BoyJ (Cd45.1 mice), B6.129P2(Cg)-Rorctm2Litt/J (Rorγ−/−), STOCK Il-17atm1.1(icre)Stck/J, B6.129 × 1-Gt(ROSA)26Sortm1(EYFP)cos/J, B6.129(Cg)-Foxp3tm3(DTR/GFP)Ayr/J (Foxp3GFP) and C57BL/6-Foxp3tm1Flv/J (Foxp3mRFP) mice were obtained from The Jackson Laboratory. IL-17 fate reporter mice (Il17aCreRosa26eYFP) were created in our laboratory by breeding STOCK IL17atm1.1(icre)Stck/J and B6.129 × 1-Gt(ROSA)26Sortm1(EYFP)cos/J. Foxp3 fate reporter mice (Foxp3YFP/CreRosa26tdTomato) were created in our laboratory by breeding B6.129(Cg)-Foxp3tm4(YFP/cre)Ayr/J and B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J. IL-17 fate reporter mice were bred with Foxp3mRFP mice to create Th17eYFP-Foxp3mRFP fate reporter (Il17aCreRosa26eYFP xFoxp3tm1Flv) mice. All animal experiments were approved by the University of Pittsburgh Institutional Animal Care and Use Committee (15045926). Six- to eight-week-old female mice were used in the experiments. In all experiments tumour-bearing mice were randomly allocated to experimental groups. In experiments where in vivo immunological assays were performed, the variation within groups allowed the detection of differences with 4–5 mice per group.
+ Open protocol
+ Expand
3

Transgenic Mice for Cardiac Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BAC transgene Tbx5CreERT2 was constructed from the BAC clone RP23-267B1570 (link) by replacement of exon 2 of Tbx5 with a CreERT2 cassette at the first methionine of the open reading frame in EL250 cells23 (link),71 (link). The BAC-Tbx5CreERT2 transgenes were crossed with Rosa26ReYFP/eYFP transgenic mice (B6.129×1-Gt(ROSA)26Sortm1(EYFP)Cos/J) from Jackson laboratories stock# 006148, in order to produce Tbx5CreERT2/Rosa26ReYFP/eYFP mice employed in this study. The Tbx5CreERT2/+/Rosa26ReYFP/+/Rosa26RiDTR/+ was created using the tamoxifen-induced Rosa26RiDTR/iDTR transgene72 (link) (Jackson laboratories stock# 007900) provided by the Klinakis lab (BRFAA).
All animal work has been approved by the BRFAA ethics committee and the Attica Veterinary Department (Animal Licence; 60876/23-1-20). All animals used were 2–3 months of age upon the time of ischemia/reperfusion (I/R) or isoproterenol administration experiments following relevant inclusion/exclusion guideline criteria73 (link).
+ Open protocol
+ Expand
4

Generating Oct1-Deficient Mouse ESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
All mice were C57BL/6J background. Oct1 germline-deficient ESCs were generated by intercrossing heterozygous Pou2f1-/+ mice (Wang et al., 2004 (link)) to generate a 1:2:1 ratio of Pou2f1-/-: Pou2f1-/+: Pou2f1+/+ embryonic offspring. ESCs were derived from preimplantation blastocysts and genotyped. Heterozygous ESCs were not studied further. Littermate WT ESCs lines constituted the controls for these experiments. Oct1 inducible-conditional ESCs were generated by first separately crossing mice with the Pou2f1 conditional (floxed) allele (Shakya et al., 2015b (link)) to the YFP reporter B6.129 × 1-Gt(ROSA)26Sortm1(EYFP)Cos/J (Jackson labs #006148) and inducible cre transgenic line B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J (Jackson labs #008463). Resulting Pou2f1fl/fl animals were intercrossed to generate embryonic Pou2f1fl/fl offspring in which LSL-YFP was expressed from one Rosa26 allele and Cre-ERT2 was expressed from the other. Parent ESCs were derived from these preimplantation blastocysts. The parent lines constituted the controls for derived 4-OHT-treated, Pou2f1Δ/Δ:YFP+ lines. Cell lines were routinely authenticated by genotyping. Mycoplasma testing was conducted regularly in-house using a previously published method (Molla Kazemiha et al., 2009 (link)). Cells were negative throughout the study.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!